May I begin by joining colleagues from across the House in paying tribute to the former hon. Member for Redditch? I entered the House at the same time as her. She was a much-loved and popular colleague. I send, as I know so many do, condolences to her family and her many friends.
With permission, Madam Deputy Speaker, I shall make a statement about the action the Government are taking to improve patient choice as a way to help reduce NHS waiting times, one of the Government’s five key priorities.
There are currently significant variations in waiting times across the country, and sometimes even within the same integrated care system. Analysis from the Patients Association suggests that improved patient choice can reduce waiting times by up to three months. When he took office last year, the Prime Minister promised to make it easier for patients to make a meaningful choice and to raise public awareness of the patient’s right to choose.
Because of the pandemic, we have an NHS waiting list of over 7.3 million. Of that number, around 80% are waiting for outpatient appointments and around 20% are waiting for operations. Greater patient choice will help us address this built up demand including, where appropriate, opening more routes for NHS patients to get treatment free at the point of access in the independent sector, provided it meets NHS costs and standards, because we should use all available capacity in tackling the pandemic backlogs. For example, for patients currently waiting for ear, nose and throat treatment in London, the wait could be up to four months shorter with another provider, or with trauma and orthopaedics in the north-west, choosing another provider in the same region could cut someone’s wait by three months.
Empowering patients to exercise their right to choose was one of the recommendations of the elective recovery taskforce, which identified it as a vital way of delivering the post-pandemic recovery. While we were addressing the 78-week backlog, analysis showed that 50% of those who were waiting more than 78 weeks for elective care were in just 11 trusts, which reinforced the opportunity offered by raising awareness of patient choice and making it easier for patients to exercise that choice in a meaningful way.
As well as cutting waiting lists, choice empowers patients to decide which aspects of the hospital service matter most to them. Patients themselves can prioritise the speed of care, alongside other factors such as distance travelled and the Care Quality Commission rating of the provider, or they may have had previous care from a consultant-led team and want to return to that team. We believe that empowering the patient is an intrinsically good thing, and we also believe that it cannot be the preserve of the groups with the sharpest elbows; it must be open to all. Research from the King’s Fund has found that
“older respondents, those with no qualifications, and those from a mixed and non-white background were more likely to value choice.”
When we combine improved patient choice with better real-time data and greater transparency, we can drive up standards. When patients know much more about how their local hospital is performing, the pressure is on poor performers to close the gap with their near neighbours, where patients are often being treated more quickly.
The case for patient choice is clear, so with the aim of improving it, we are announcing significant changes in a number of areas. The first is technology. More than 30 million people have now signed up for the NHS App, and our target is for three quarters of all adults in England to be registered by next March. The app is already giving patients an improved “front door” for NHS services, and we are continuing to build on that. When GPs make a referral, they will make a shortlist of the five most suitable providers, and patients will be able to choose from the shortlist on the app. In March we completed the work of supplying a single list of providers for these shortlists, irrespective of whether the services are commissioned locally or nationally. While the Opposition’s plan to organise waiting lists on a regional basis might look like a good idea on paper, in reality it would add an extra layer of bureaucracy, whereas national lists under this Conservative Government will empower patients to choose treatment wherever they like. For example, a patient registered in Sheffield might happily choose to receive treatment in Manchester, particularly if family members there could help with the patient’s care and recovery.
The second area of work is improving the experience of those who are already on waiting lists, so that they can obtain treatment more quickly. From October this year, patients who have waited more than 40 weeks for an appointment, or who have a decision to treat but do not have a treatment date, will be able to request a transfer to another provider with a shorter waiting list. It is our ambition to expand that offer to other groups of long waiters, progressively lowering the waiting time towards 18 weeks as fast as is clinically possible.
Our third focus is on communications. We want to increase public awareness of today’s announcement through a national campaign, with the particular aim of reaching the groups who are most likely to benefit from greater choice as well as those least likely to exercise it. We will also ensure that general practitioners, and others who refer patients for consultant-led care, are offering more patient choice and are supported with the right training and technology.
Fourthly, we will focus on transparency. Real-time information on performance will be made more transparent to patients so that they can gain a clearer understanding of the variations from place to place, which will help them to exercise informed choice. We have worked to make ratings by the Care Quality Commission available and accessible to all, and we are merging the “My Planned Care” platform with the NHS website.
The Labour party has been busy announcing initiatives that we already have under way, such as expanding the NHS App, embracing virtual wards and stopping kids from vaping, but while its members have been busy talking in England and failing to act on behalf of patients in Wales, we have been busy acting to empower patients, and today’s announcement is another example of that. We are committed to cutting NHS waiting lists, and the measures that we have announced will help us to do that—by empowering patients to gain access to faster treatment in hospitals with available capacity; by giving patients technology enabling them to exercise their right to choose, and giving them the information that will help them to make that choice; by increasing communication to raise public awareness of the right to choose; and by fostering much greater transparency and, through funding, following the patient, to encourage trusts to improve their offer to patients to better match the service offered in hospitals elsewhere.
Taken together, those measures will enable patients to access treatment more quickly and meet the Government’s priority of reducing NHS waiting lists. I commend this statement to the House.